Anti-protective antigen IgG enzyme-linked immunosorbent assay for diagnosis of cutaneous anthrax in India

Clinical and Vaccine Immunology

Volumn 19, Issue 8, 2012, Pages 1238-1242

  Ghosh, N ^a   Goel, A K ^a  

^a DEFENCE RESEARCH AND DEVELOPMENT ESTABLISHMENT   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM ANTIBODY; IMMUNOGLOBULIN G;

ANTHRAX; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOASSAY; INDIAN; MAJOR CLINICAL STUDY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROCESS DEVELOPMENT; SENSITIVITY AND SPECIFICITY; SKIN INFECTION;

ANTHRAX; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACILLUS ANTHRACIS; BACTERIAL TOXINS; CLINICAL LABORATORY TECHNIQUES; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOGLOBULIN G; INDIA; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; SKIN DISEASES, BACTERIAL;

EID: 84864566026     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00154-12     Document Type: Article

References (30)

1. Boyer AE, et al. 2011. Lethal factor toxemia and anti-protective antigen antibody activity in naturally acquired cutaneous anthrax. J. Infect. Dis. 204:1321-1327.
2. Caksen H, Arabaci F, Abuhandan M, Tuncer O, Cesur Y. 2001. Cutaneous anthrax in eastern Turkey. Cutis 67:488-492. (Pubitemid 33756297)
3. Choi YH, et al. 2000. Scrub typhus: radiological and clinical findings. Clin. Radiol. 55:140-144. (Pubitemid 32054538)
4. Cinquetti G, et al. 2009. Three related cases of cutaneous anthrax in France: clinical and laboratory aspects. Medicine (Baltimore) 88:371-375.
5. Collier RJ, Young JAT. 2003. Anthrax toxin. Annu. Rev. Cell Dev. Biol. 19:45-70. (Pubitemid 37487342)
6. Edwards MS. 1992. Anthrax, p 1053-1056. In Feigin RD, Cherry JD (ed), Textbook of pediatric infectious diseases, 3rd ed, vol 1. W. B. Saunders, Philadelphia, PA.
7. Ezzell JW, Welkos SL. 1999. The capsule of Bacillus anthracis, a review. J. Appl. Microbiol. 87:250.
8. Gucluer H, Ergun T, Demircay Z. 1999. Ecthyma gangrenosum. Int. J. Dermatol. 38:299-302. (Pubitemid 29189638)
9. Inglesby TV, et al. 1999. Anthrax as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA 281:1735-1745. (Pubitemid 29226485)
10. Kao GF, Evancho CD, Ioffe O, Lowitt MH, Dumler JS. 1997. Cutaneous histopathology of Rocky Mountain spotted fever. J. Cutan. Pathol. 24: 604-610. (Pubitemid 27515697)
11. Kumar A, Kanungo R, Badrinath S. 2000. Anthrax in Pondicherry, South India. J. Med. Microbiol. 49:1129.
12. Merchant SR, Taboada J. 1995. Systemic diseases with cutaneous manifestations. Vet. Clin. North Am. Small Anim. Pract. 25:945-959.
13. Mock M, Mignot T. 2003. Anthrax toxins and the host: a story of intimacy. Cell. Microbiol. 5:15-23. (Pubitemid 36395117)
14. Motulsky HJ. 2007. Prism 5 statistics guide. GraphPad Software Inc., San Diego CA.
15. Patil RR. 2010. Anthrax: public health risk in India and socio-environmental determinants. Indian J. Community Med. 35:189-190.
16. Paweska JT, Burt FJ, Swanepoel R. 2005. Validation of IgG-sandwich and IgM-capture ELISA for the detection of antibody to Rift Valley fever virus in humans. J. Virol. Methods 124:173-181. (Pubitemid 40138794)
17. Pitt ML, et al. 2001. In vitro correlate of immunity in a rabbit model of inhalational anthrax. Vaccine 19:4768-4773. (Pubitemid 32800762)
18. Quinn CP, et al. 2004. Immune responses to Bacillus anthracis protective antigen in patients with bioterrorism-related cutaneous or inhalation anthrax. J. Infect. Dis. 190:1228-1236. (Pubitemid 39287748)
19. Quinn CP, et al. 2002. Specific, sensitive, and quantitative enzyme-linked immunosorbent assay for human immunoglobulin G antibodies to anthrax toxin protective antigen. Emerg. Infect. Dis. 8:1103-1110. (Pubitemid 35257002)
20. Rao TN, et al. 2009. A mini-outbreak of cutaneous anthrax in Vizianagaram District, Andhra Pradesh, India. Indian J. Dermatol. Venereol. Leprol. 75:416-418.
21. Senol M, Ozcan A, Karincaoglu Y, Aydin A, Ozerol IH. 1999. Tularemia: a case transmitted from a sheep. Cutis 63:49-51.
22. Shieh WJ, et al. 2003. The critical role of pathology in the investigation of bioterrorism-related cutaneous anthrax. Am. J. Pathol. 163:1901-1910.
23. Shlyakhov E, Rubinstein E. 1996. Evaluation of the anthraxin skin test for diagnosis of acute and past human anthrax. Eur. J. Clin. Microbiol. Infect. Dis. 15:242-245. (Pubitemid 26125764)
24. Shlyakhov EN, Shvarts SA, Gruz EV. 1973. Anthrax. Biological and immunological principles of diagnosis and prevention. Communication 7. Diagnosis of anthrax by means of anthraxin. J. Hyg. Epidemiol. Microbiol. Immunol. 17:279-284.
25. Singh Y, Klimpel KR, Goel S, Swain PK, Leppla SH. 1999. Oligomerization of anthrax toxin protective antigen and binding of lethal factor during endocytic uptake into mammalian cells. Infect. Immun. 67:1853-1859. (Pubitemid 29144406)
26. Sirisanthana T, Brown AE. 2002. Anthrax of the gastrointestinal tract. Emerg. Infect. Dis. 8:649-651. (Pubitemid 34764726)
27. Turk BE. 2007. Manipulation of host signalling pathways by anthrax toxins. Biochem. J. 402:405-417. (Pubitemid 46423878)
28. Turnbull PC, Doganay M, Lindeque PM, Aygen B, McLaughlin J. 1992. Serology and anthrax in humans, livestock and Etosha National Park wildlife. Epidemiol. Infect. 108:299-313.
29. Wallace R. 2008. Maxey-Rosenau-Last public health and preventive medicine, 15th ed. McGraw-Hill Companies, New York, NY.
30. Woods CW, et al. 2004. Risk factors for human anthrax among contacts of anthrax-infected livestock in Kazakhstan. Am. J. Trop. Med. Hyg. 71:48-52. (Pubitemid 38902643)